Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$131.82

0.29 (0.22%)

, BAYRY

Bayer

$133.06

0.01 (0.01%)

06:04
06/13/17
06/13
06:04
06/13/17
06:04

Bayer, J&J cleared of liability in second Xarelto trial, Reuters reports

Bayer (BAYRY) and Johnson & Johnson (JNJ) have been cleared of liability by a federal jury in the second trial stemming from thousands of lawsuits blaming injuries on Xarelto, a blood thinning drug, Reuters reports. Reference Link

JNJ

Johnson & Johnson

$131.82

0.29 (0.22%)

BAYRY

Bayer

$133.06

0.01 (0.01%)

  • 13

    Jun

  • 15

    Jun

  • 26

    Jun

JNJ Johnson & Johnson
$131.82

0.29 (0.22%)

06/06/17
WELS
06/06/17
NO CHANGE
WELS
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently reported that Amazon (AMZN) is considering going into the prescription pharmacy business in the U.S., Wells Fargo surveyed nearly 2,900 U.S. adults and found that 54% of those polled said they would use or would probably use "Amazon Pharmacy." While the e-commerce giant has not confirmed its U.S. pharmacy interest, if it did enter the market analyst David Maris believes it could see fast adoption and "usher in a new age of price transparency." Maris also wonders if pharmacy "may be just the beginning" and if Amazon eyes the "even larger prize" of fully integrated digital healthcare. Publicly traded large-cap pharmaceuticals companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens (WBA), Fred's (FRED) and Rite Aid (RAD).
06/07/17
FBCO
06/07/17
NO CHANGE
Target $38
FBCO
Outperform
ASCO meeting highlights pressure on Pfizer cancer assets, says Credit Suisse
Credit Suisse analyst Vamil Divan said he came away from the ASCO meeting feeling like positive progress by competitors is increasing the pressure on Pfizer's (PFE) cancer assets, specifically pointing to positive data for Roche's (RHHBY) Alecensa, Johnson & Johnson's (JNJ) Zytiga and Eli Lilly's (LLY) abemaciclib. Additionally, competition in the immune-oncology and PARP spaces will make it more challenging for Pfizer to gain traction, added Divan. He keeps an Outperform rating on Pfizer, citing valuation and its dividend yield, but he has concerns about its upcoming patent expirations and growth products.
06/09/17
FBCO
06/09/17
NO CHANGE
FBCO
Outperform
Tesaro prostate study suspension due to fast enrollment, says Credit Suisse
After speaking to Tesaro (TSRO), after they spoke to their partner Johnson & Johnson (JNJ), Credit Suisse analyst Alethia Young said the news of the companies' suspension of participant recruitment in the study of niraparib in prostate cancer is actually positive, since it is due to the trial enrolling faster than expected. The suspension has nothing to do with safety or efficacy and is not a clinical hold, but is due to having too many patients in the first part of trial, Young was told. She maintains an Outperform rating on Tesaro shares.
06/12/17
RHCO
06/12/17
NO CHANGE
RHCO
Misunderstanding creates buying opportunity in Tesaro stock, says SunTrust
SunTrust analyst Peter Lawson says that the suspension of participant recruitment by Johnson & Johnson (JNJ) for a study of Tesaro's (TSRO) PARP inhibitor Zejula in prostate cancer "is being incorrectly viewed as a clinical hold." After speaking with J&J, Lawson says that the suspension was not due to clinical or safety issues, but to overly fast enrollment. The analyst says that the early data on PARP inhibitors in prostate cancer has been "encouraging." He believes that the misunderstanding has created a buying opportunity in Tesaro stock. .
BAYRY Bayer
$133.06

0.01 (0.01%)

01/06/17
JPMS
01/06/17
NO CHANGE
Target $128
JPMS
Overweight
Monsanto shares are mispriced, says JPMorgan
JPMorgan analyst Jeffrey Zekauskas says Monsanto (MON) shares are mispriced and offer an attractive risk/reward proposition. A first catalyst for the shares would be regulatory agreement in the Dow Chemical (DOW)/DuPont (DD) transaction, Zekauskas tells investors in a research note. The analyst thinks a favorable resolution to the Dow/DuPont merger would be seen as improving the probability of the success of the Bayer/Monsanto transaction. He notes that Bayer has agreed to purchase Monsanto for $128 per share in cash, which represents 21% appreciation potential should the deal close by year-end. Zekauskas thinks a "reasonable floor" price for Monsanto shares, should the deal fail, is $102. He keeps an Overweight rating on the name with a $128 price target.
03/03/17
JPMS
03/03/17
NO CHANGE
Target $128
JPMS
Overweight
EU approvals of other ag deals may narrow Monsanto deal spread, says JPMorgan
JPMorgan analyst Jeffrey Zekauskas said commentary from the CEOs of DuPont (DD) and Syngenta (SYT) and press reports from Europe suggest that their deals with Dow Chemical (DOW) and ChemChina, respectively, are likely to be approved. Approvals from Europe for those deals may "trigger a meaningful closing of the arbitrage spread" in Monsanto (MON) shares versus Bayer's (BAYRY) offer price, Zekauskas tells investors. He recommends buying Monsanto shares at current levels for this reason, adding that he believes the shares would only fall about 2.5%, or down to $112, in the event of the Bayer deal falling through. Zekauskas keeps an Overweight rating and $128 price target on Monsanto shares, which closed yesterday at just below $115 per share.
04/06/17
JPMS
04/06/17
NO CHANGE
Target $128
JPMS
Overweight
Monsanto shares offer 'excellent' risk/reward proposition, says JPMorgan
JPMorgan analyst Jeffrey Zekauskas says shares of Monsanto (MON) at current levels offer an "excellent" risk/reward proposition. The analyst views capital appreciation potential to the end of 2017 as 11% or a 15% annual return. He sees downside risk of only 3%, to $112 per share, in the event that Bayer (BAYRY) is not able to consummate the acquisition. Zekauskas has increased confidence in the deal closing following recent regulatory rulings and keeps an Overweight rating on the name with a $128 price target.
04/10/17
PIPR
04/10/17
NO CHANGE
Target $17
PIPR
Overweight
OncoMed price target lowered to $17 from $26 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target for OncoMed (OMED) to $17 from $26 following two negative announcements, namely that the Phase II YOSEMITE study of demcizumab in first line pancreatic cancer failed and Bayer (BAYRY) returned rights for ipafricept and vantictumab. The analyst also notes that now partner Celgene (CELG) will review all data on demcizumab including Phase II DENALI non-small cell lung cancer data and Phase Ib combo data with KEYTRUDA, although he does not expect Celgene to exercise its option. Tenthoff reiterates an Overweight rating on OncoMed's shares.

TODAY'S FREE FLY STORIES

02:05
04/24/18
04/24
02:05
04/24/18
02:05
General news
Asian Market Wrap: »

Asian Market Wrap:…

DLNG

Dynagas LNG

$9.46

-0.18 (-1.87%)

21:09
04/23/18
04/23
21:09
04/23/18
21:09
Downgrade
Dynagas LNG rating change at Wells Fargo »

Dynagas LNG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALPMY

Astellas Pharma

21:02
04/23/18
04/23
21:02
04/23/18
21:02
Hot Stocks
Astellas Pharma submits NDA for approval of Gilteritinib in AML »

Astellas Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

VZ

Verizon

$48.66

0.74 (1.54%)

, KO

Coca-Cola

$43.96

0.22 (0.50%)

20:25
04/23/18
04/23
20:25
04/23/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

VZ

Verizon

$48.66

0.74 (1.54%)

KO

Coca-Cola

$43.96

0.22 (0.50%)

MMM

3M

$216.01

-1.71 (-0.79%)

LMT

Lockheed Martin

$358.59

6.645 (1.89%)

UTX

United Technologies

$123.45

0.38 (0.31%)

CAT

Caterpillar

$153.96

0.72 (0.47%)

LLY

Eli Lilly

$80.25

1.16 (1.47%)

NEE

NextEra Energy

$161.23

0.46 (0.29%)

BIIB

Biogen

$259.30

-3.61 (-1.37%)

SHW

Sherwin-Williams

$387.51

-4.895 (-1.25%)

TRV

Travelers

$137.25

0.4 (0.29%)

FCX

Freeport McMoRan

$18.80

-0.56 (-2.89%)

PCAR

Paccar

$69.43

0.24 (0.35%)

GLW

Corning

$27.51

-0.05 (-0.18%)

FITB

Fifth Third

$31.92

0.49 (1.56%)

CNC

Centene

$110.61

-0.03 (-0.03%)

WAT

Waters

$209.48

1.23 (0.59%)

HBAN

Huntington Bancshares

$15.01

0.245 (1.66%)

QSR

Restaurant Brands

$53.50

-1.16 (-2.12%)

WAB

Wabtec

$88.07

0.53 (0.61%)

PII

Polaris Industries

$120.90

1.28 (1.07%)

HOG

Harley-Davidson

$41.00

-0.03 (-0.07%)

JBLU

JetBlue

$19.90

0.03 (0.15%)

SC

Santander Consumer

$15.71

0.03 (0.19%)

GPK

Graphic Packaging

$16.00

0.14 (0.88%)

SLCA

U.S. Silica

$27.56

-0.42 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 30

    Apr

  • 07

    May

  • 08

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 11

    May

  • 15

    May

  • 15

    May

  • 15

    May

  • 18

    May

  • 21

    May

  • 30

    May

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 13

    Jun

  • 15

    Jun

  • 24

    Jul

  • 23

    Oct

  • 14

    Dec

BOALY

Boral Ltd.

20:18
04/23/18
04/23
20:18
04/23/18
20:18
Earnings
Boral Ltd sees FY18 EBITDA contribution from property at AUD55M-AUD65M »

Sees Boral Australia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$80.25

1.16 (1.47%)

, INCY

Incyte

$68.15

-0.26 (-0.38%)

20:14
04/23/18
04/23
20:14
04/23/18
20:14
Hot Stocks
FDA recommends approval of Incyte/Eli Lilly's Baricitinib 2mg, but not 4mg in RA »

Eli Lilly (LLY) and…

LLY

Eli Lilly

$80.25

1.16 (1.47%)

INCY

Incyte

$68.15

-0.26 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 01

    May

  • 07

    May

  • 21

    May

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

VBTX

Veritex

$28.01

0.11 (0.39%)

19:35
04/23/18
04/23
19:35
04/23/18
19:35
Earnings
Veritex reports Q1 EPS 42c, consensus 40c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Sep

FSUMY

Fortescue Metal

19:15
04/23/18
04/23
19:15
04/23/18
19:15
Hot Stocks
Breaking Hot Stocks news story on Fortescue Metal  »

Fortescue Metal reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$27.70

0.1 (0.36%)

, CDNS

Cadence Design

$36.75

-0.27 (-0.73%)

19:00
04/23/18
04/23
19:00
04/23/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SANM

Sanmina

$27.70

0.1 (0.36%)

CDNS

Cadence Design

$36.75

-0.27 (-0.73%)

HLX

Helix Energy

$6.24

-0.245 (-3.78%)

TRMB

Trimble

$36.13

-0.44 (-1.20%)

RUSHA

Rush Enterprises

$43.00

-0.3 (-0.69%)

SLM

Sallie Mae

$11.68

0.015 (0.13%)

ZION

Zions Bancorp

$54.27

0.47 (0.87%)

AMP

Ameriprise

$145.45

1.74 (1.21%)

GOOG

Alphabet

$1,067.70

-5.03 (-0.47%)

ZYME

Zymeworks

$12.08

0.095 (0.79%)

TNDM

TNDM

LQ

La Quinta

$19.55

0.09 (0.46%)

BP

BP

$43.92

0.415 (0.95%)

DGICA

Donegal Group

$15.07

-0.11 (-0.72%)

AMTD

TD Ameritrade

$61.21

-0.04 (-0.07%)

WHR

Whirlpool

$150.31

0.885 (0.59%)

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

BRO

Brown & Brown

$26.56

0.6 (2.31%)

ABX

Barrick Gold

$12.93

-0.23 (-1.75%)

OI

Owens-Illinois

$21.76

0.13 (0.60%)

EPZM

Epizyme

$15.25

-0.65 (-4.09%)

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

CASA

Casa Systems

$29.81

-0.35 (-1.16%)

BBBY

Bed Bath & Beyond

$17.35

0.22 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 12

    Jun

  • 26

    Apr

UAL

United Continental

$70.32

-1.405 (-1.96%)

18:45
04/23/18
04/23
18:45
04/23/18
18:45
Periodicals
United Continental CEO to forego 2017 bonus, Bloomberg reports »

United Continental CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

UAL

United Continental

$70.32

-1.405 (-1.96%)

18:37
04/23/18
04/23
18:37
04/23/18
18:37
Hot Stocks
United Continental chairman Milton will not stand for reelection »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

INFY

Infosys

$17.43

0.05 (0.29%)

18:12
04/23/18
04/23
18:12
04/23/18
18:12
Hot Stocks
Infosys sees FY18 revenue growth trending at 7.2% rate »

Comments from the Infosys…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

SFNC

Simmons First National

$28.95

0.2 (0.70%)

18:04
04/23/18
04/23
18:04
04/23/18
18:04
Earnings
Simmons First National reports Q1 core EPS 57c, consensus 52c »

Reports Q1 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 14

    May

  • 24

    Sep

HLX

Helix Energy

$6.24

-0.245 (-3.78%)

18:01
04/23/18
04/23
18:01
04/23/18
18:01
Earnings
Helix Energy reports Q1 EPS (2c), consensus (6c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

GLRE

Greenlight Capital Re

, AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

17:50
04/23/18
04/23
17:50
04/23/18
17:50
Hot Stocks
Einhorn says Assured Guaranty has a lot of exposure to Puerto Rico »

Says Assured…

GLRE

Greenlight Capital Re

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 04

    May

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

17:45
04/23/18
04/23
17:45
04/23/18
17:45
Hot Stocks
Tivity Health falls 19% after Q1 revenue misses estimates »

Shares of Tivity Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 12

    Jun

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

17:42
04/23/18
04/23
17:42
04/23/18
17:42
Earnings
Tivity Health affirms FY18 EPS 2.12-$2.20, consensus $2.16 »

Backs FY18 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 12

    Jun

GLRE

Greenlight Capital Re

, AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

17:42
04/23/18
04/23
17:42
04/23/18
17:42
Hot Stocks
Greenlight Capital's Einhorn says Assured Guaranty has no room for losses »

Says Assured Guaranty …

GLRE

Greenlight Capital Re

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 04

    May

HD

Home Depot

$177.73

0.68 (0.38%)

, LOW

Lowe's

$84.34

0.71 (0.85%)

17:40
04/23/18
04/23
17:40
04/23/18
17:40
Initiation
Home Depot, Lowe's, Tractor Supply, O'Reilly Automotive, AutoZone, At Home Group, National Vision initiated at Wells Fargo »

Home improvement and…

HD

Home Depot

$177.73

0.68 (0.38%)

LOW

Lowe's

$84.34

0.71 (0.85%)

TSCO

Tractor Supply

$61.64

1.33 (2.21%)

ORLY

O'Reilly Automotive

$222.54

1.06 (0.48%)

AZO

AutoZone

$599.45

3.63 (0.61%)

HOME

At Home Group

$34.69

-0.305 (-0.87%)

EYE

National Vision

$31.57

-0.02 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    May

  • 12

    Jun

WBS

Webster Financial

$59.94

0.555 (0.93%)

17:37
04/23/18
04/23
17:37
04/23/18
17:37
Hot Stocks
Webster Financial increases dividend 7c to 33c »

Webster Financial, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SCHW

Charles Schwab

$55.37

0.37 (0.67%)

17:36
04/23/18
04/23
17:36
04/23/18
17:36
Hot Stocks
Charles Schwab chairman Charles Schwab sells 250K shares »

The chairman of brokerage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

NDAQ

Nasdaq

$86.92

-0.52 (-0.59%)

17:36
04/23/18
04/23
17:36
04/23/18
17:36
Periodicals
Nasdaq proposes to let companies pick where their shares trade, Reuters says »

Nasdaq said it plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

GLRE

Greenlight Capital Re

, AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

17:35
04/23/18
04/23
17:35
04/23/18
17:35
Hot Stocks
Greenlight Capital's Einhorn says short Assured Guaranty »

David Einhorn, president,…

GLRE

Greenlight Capital Re

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 04

    May

SFE

Safeguard Scientifics

$12.25

-0.25 (-2.00%)

17:32
04/23/18
04/23
17:32
04/23/18
17:32
Hot Stocks
Safeguard Scientifics enters agreement with Sierra Capital »

Safeguard Scientifics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

EPZM

Epizyme

$15.25

-0.65 (-4.09%)

17:31
04/23/18
04/23
17:31
04/23/18
17:31
Hot Stocks
Breaking Hot Stocks news story on Epizyme »

Epizyme down 19% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.